Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1994 Jul;1(4):445–449. doi: 10.1128/cdli.1.4.445-449.1994

Antineurofilament and antiretinal antibodies in AIDS patients with cytomegalovirus retinitis.

D F Rosberger 1, S L Tshering 1, B Polsky 1, M H Heinemann 1, R F Klein 1, S Cunningham-Rundles 1
PMCID: PMC368285  PMID: 8556483

Abstract

Sera obtained from AIDS patients with cytomegalovirus (CMV) retinitis before and after treatment with foscarnet, AIDS patients with human immunodeficiency virus (HIV) retinopathy, AIDS patients without retinal disease, and normal healthy controls with and without positive CMV serologies were assayed for the presence of antibodies against the 200-kDa outer, 160-kDa middle, and 68-kDa core subunits of the neurofilament triplet. Additional studies were performed to determine the presence of antibodies reactive with proteins extracted from crude human retinal antigen preparations. Antibodies against the 200-, 260-, and 68-kDa proteins of the neurofilament triplet were detected in 15 of 15 AIDS patients with CMV retinitis. The expression of these antibodies was unaffected, qualitatively, by successful treatment with foscarnet. In contrast, only 30% of patients with HIV retinopathy unrelated to CMV, fewer than 35% of AIDS patients with positive CMV titers but without evident retinitis, and fewer than 25% of healthy controls with positive or negative CMV titers possessed antibodies against any of the triplet proteins (P < 0.001). Antibodies against several clusters of retinal antigens were also identified in the sera of patients with CMV retinitis. In summary, the data indicate that retinal elements damaged by CMV infection induce an antibody response against the 200-, 160-, and 68kDa components of the neurofilament triplet as well as other, as yet undefined retinal antigens.

Full text

PDF
445

Images in this article

447Image
on p.447
447Image
on p.447
448Image
on p.448

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aoki T., Gibbs C. J., Jr, Sotelo J., Gajdusek D. C. Heterogeneic autoantibody against neurofilament protein in the sera of animals with experimental kuru and Creutzfeldt-Jakob disease and natural scrapie infection. Infect Immun. 1982 Oct;38(1):316–324. doi: 10.1128/iai.38.1.316-324.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aweeka F., Gambertoglio J., Mills J., Jacobson M. A. Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis. Antimicrob Agents Chemother. 1989 May;33(5):742–745. doi: 10.1128/aac.33.5.742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bloom J. N., Palestine A. G. The diagnosis of cytomegalovirus retinitis. Ann Intern Med. 1988 Dec 15;109(12):963–969. doi: 10.7326/0003-4819-109-12-963. [DOI] [PubMed] [Google Scholar]
  4. Freeman W. R., Lerner C. W., Mines J. A., Lash R. S., Nadel A. J., Starr M. B., Tapper M. L. A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome. Am J Ophthalmol. 1984 Feb;97(2):133–142. doi: 10.1016/s0002-9394(14)76082-9. [DOI] [PubMed] [Google Scholar]
  5. Galbraith G. M., Emerson D., Fudenberg H. H., Gibbs C. J., Gajdusek D. C. Antibodies to neurofilament protein in retinitis pigmentosa. J Clin Invest. 1986 Oct;78(4):865–869. doi: 10.1172/JCI112672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Grunwald G. B., Klein R., Simmonds M. A., Kornguth S. E. Autoimmune basis for visual paraneoplastic syndrome in patients with small-cell lung carcinoma. Lancet. 1985 Mar 23;1(8430):658–661. doi: 10.1016/s0140-6736(85)91326-1. [DOI] [PubMed] [Google Scholar]
  7. Holland G. N., Pepose J. S., Pettit T. H., Gottlieb M. S., Yee R. D., Foos R. Y. Acquired immune deficiency syndrome. Ocular manifestations. Ophthalmology. 1983 Aug;90(8):859–873. doi: 10.1016/s0161-6420(83)80009-8. [DOI] [PubMed] [Google Scholar]
  8. Holland G. N., Sidikaro Y., Kreiger A. E., Hardy D., Sakamoto M. J., Frenkel L. M., Winston D. J., Gottlieb M. S., Bryson Y. J., Champlin R. E. Treatment of cytomegalovirus retinopathy with ganciclovir. Ophthalmology. 1987 Jul;94(7):815–823. doi: 10.1016/s0161-6420(87)33534-1. [DOI] [PubMed] [Google Scholar]
  9. Jabs D. A., Enger C., Bartlett J. G. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol. 1989 Jan;107(1):75–80. doi: 10.1001/archopht.1989.01070010077031. [DOI] [PubMed] [Google Scholar]
  10. Jacobson M. A., Crowe S., Levy J., Aweeka F., Gambertoglio J., McManus N., Mills J. Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS. J Infect Dis. 1988 Oct;158(4):862–865. [PubMed] [Google Scholar]
  11. Jacobson M. A., O'Donnell J. J., Mills J. Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Antimicrob Agents Chemother. 1989 May;33(5):736–741. doi: 10.1128/aac.33.5.736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kornguth S. E., Kalinke T., Grunwald G. B., Schutta H., Dahl D. Anti-neurofilament antibodies in the sera of patients with small cell carcinoma of the lung and with visual paraneoplastic syndrome. Cancer Res. 1986 May;46(5):2588–2595. [PubMed] [Google Scholar]
  13. Kornguth S. E., Klein R., Appen R., Choate J. Occurrence of anti-retinal ganglion cell antibodies in patients with small cell carcinoma of the lung. Cancer. 1982 Oct 1;50(7):1289–1293. doi: 10.1002/1097-0142(19821001)50:7<1289::aid-cncr2820500711>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  14. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  15. Lehoang P., Girard B., Robinet M., Marcel P., Zazoun L., Matheron S., Rozenbaum W., Katlama C., Morer I., Lernestedt J. O. Foscarnet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology. 1989 Jun;96(6):865–874. doi: 10.1016/s0161-6420(89)32824-7. [DOI] [PubMed] [Google Scholar]
  16. Liem R. K., Hutchison S. B. Purification of individual components of the neurofilament triplet: filament assembly from the 70 000-dalton subunit. Biochemistry. 1982 Jun 22;21(13):3221–3226. doi: 10.1021/bi00256a029. [DOI] [PubMed] [Google Scholar]
  17. Linder E., Kurki P., Andersson L. C. Autoantibody to "intermediate filament" in infectious mononucleosis. Clin Immunol Immunopathol. 1979 Dec;14(4):411–417. doi: 10.1016/0090-1229(79)90093-x. [DOI] [PubMed] [Google Scholar]
  18. Masur H., Lane H. C., Palestine A., Smith P. D., Manischewitz J., Stevens G., Fujikawa L., Macher A. M., Nussenblatt R., Baird B. Effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine on serious cytomegalovirus disease in eight immunosuppressed homosexual men. Ann Intern Med. 1986 Jan;104(1):41–44. doi: 10.7326/0003-4819-104-1-41. [DOI] [PubMed] [Google Scholar]
  19. Palestine A. G., Stevens G., Jr, Lane H. C., Masur H., Fujikawa L. S., Nussenblatt R. B., Rook A. H., Manischewitz J., Baird B., Megill M. Treatment of cytomegalovirus retinitis with dihydroxy propoxymethyl guanine. Am J Ophthalmol. 1986 Jan 15;101(1):95–101. doi: 10.1016/0002-9394(86)90470-8. [DOI] [PubMed] [Google Scholar]
  20. Pepose J. S., Newman C., Bach M. C., Quinn T. C., Ambinder R. F., Holland G. N., Hodstrom P. S., Frey H. M., Foos R. Y. Pathologic features of cytomegalovirus retinopathy after treatment with the antiviral agent ganciclovir. Ophthalmology. 1987 Apr;94(4):414–424. doi: 10.1016/s0161-6420(87)33455-4. [DOI] [PubMed] [Google Scholar]
  21. Stefansson K., Marton L. S., Dieperink M. E., Molnar G. K., Schlaepfer W. W., Helgason C. M. Circulating autoantibodies to the 200,000-dalton protein of neurofilaments in the serum of healthy individuals. Science. 1985 May 31;228(4703):1117–1119. doi: 10.1126/science.4039466. [DOI] [PubMed] [Google Scholar]
  22. Thirkill C. E., FitzGerald P., Sergott R. C., Roth A. M., Tyler N. K., Keltner J. L. Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells. N Engl J Med. 1989 Dec 7;321(23):1589–1594. doi: 10.1056/NEJM198912073212307. [DOI] [PubMed] [Google Scholar]
  23. Toh B. H., Gibbs C. J., Jr, Gajdusek D. C., Goudsmit J., Dahl D. The 200- and 150-kDa neurofilament proteins react with IgG autoantibodies from patients with kuru, Creutzfeldt-Jakob disease, and other neurologic diseases. Proc Natl Acad Sci U S A. 1985 May;82(10):3485–3489. doi: 10.1073/pnas.82.10.3485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Toh B. H., Yildiz A., Sotelo J., Osung O., Holborow E. J., Kanakoudi F., Small J. V. Viral infections and IgM autoantibodies to cytoplasmic intermediate filaments. Clin Exp Immunol. 1979 Jul;37(1):76–82. [PMC free article] [PubMed] [Google Scholar]
  25. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Willard M., Simon C. Antibody decoration of neurofilaments. J Cell Biol. 1981 May;89(2):198–205. doi: 10.1083/jcb.89.2.198. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES